Press Release

Overview
Research & Clinical
Food & Beverage
News & Press Releases

Rheonix Inc. Publishes Cyclospora cayetanensis Data in Collaboration With FDA Center for Food Safety and Applied Nutrition

January 10, 2024 Press Release
Fully automated method achieves low-level detection of Cyclospora in produce samples ITHACA, N.Y. — Rheonix Inc. announces joint publication with the Food and Drug Administration (FDA) of collaborative data confirming the detection of Cyclospora cayetanensis (C. cayetanensis) in produce samples. The data verify the performance of the fully automated Rheonix C. cayetanensis™ assay developed under a Research Collaboration Agreement (RCA) between Rheonix and the Office of Applied Research and Safety Assessment (OARSA)… Read More »

Rheonix Inc. to Showcase Eurofins Listeria PatternAlert™ Customer Case Study at IAFP 2023 Annual Meeting

July 12, 2023 Press Release
Method Enables Food Producers to Rapidly Identify and Mitigate Recurring Listeria in Facilities ITHACA, N.Y. — Rheonix Inc., a manufacturer of microfluidic workstations and assays for molecular testing, will exhibit and share data at the International Association for Food Protection (IAFP) 2023 Annual Meeting in Toronto, Ontario, Canada, July 16-19. The IAFP Annual Meeting is the preeminent food safety conference focused on current and emerging food safety issues. Rheonix will showcase a… Read More »

Rheonix Inc. Develops Fully Automated Cyclospora cayetanensis Test in Collaboration With FDA Center for Food Safety and Applied Nutrition

June 27, 2023 Press Release
Molecular sample-to-answer method enables low-level detection of Cyclospora in food and environmental samples ITHACA, N.Y. — Rheonix Inc., a manufacturer of microfluidic workstations and assays for molecular testing, announced that it has completed development of a fully automated test for the detection of Cyclospora cayetanensis in food and environmental samples. The development was conducted in collaboration with scientists at the Office of Applied Research and Safety Assessment (OARSA) within the Center for… Read More »

The Eurofins Microbiology Laboratory Network Now Offering the Rheonix Listeria PatternAlert™ Assay

April 10, 2023 Press Release
Eurofins Microbiology Laboratory, Inc. in Mounds View, MN is proud to announce both its new partnership with Rheonix and new offering of the Rheonix Listeria PatternAlert™ assay for Listeria presumptive samples. The Listeria PatternAlert™ assay enables rapid identification of recurring patterns of Listeria contamination across locations and time. The assay provides a client-specific database of Listeria patterns over time. Customers can use the assay as an alternate to cultural confirmation or… Read More »

Rheonix COVID-19™ MDx Assay Receives Expanded FDA Emergency Use Authorization to Include Saliva Home Collection Kit

September 19, 2022 COVID-19, Press Release
ITHACA, N.Y. — Rheonix Inc. announced today that the United States Food and Drug Administration (FDA) has issued an expanded Emergency Use Authorization (EUA) for the Rheonix COVID-19™ MDx Assay to include home collection using the Rheonix Laboratories COVID-19 PCR Test Saliva Home Collection Kit. Rheonix’s fully automated sample-to-answer COVID-19 assay received its initial EUA for use on a range of respiratory specimens on April 29, 2020. The EUA has… Read More »

Rheonix Inc. announces opening of new laboratory, offering a low-cost COVID-19 PCR testing program

July 28, 2022 COVID-19, Press Release
Rheonix Laboratories LLC is a New York State-permitted CLIA laboratory that provides easy, streamlined testing for organizations and community members ITHACA, N.Y. — Rheonix Inc., a manufacturer of a highly advanced microfluidic molecular testing platform, announced the opening of Rheonix Laboratories LLC, a CLIA-certified clinical laboratory located in Ithaca, New York. Rheonix Laboratories is permitted by New York State to provide COVID-19 PCR testing and results, and will be partnering with… Read More »

Stephen J. Thomas, M.D., Joins Rheonix Board and Executive Team

July 21, 2022 Press Release
New addition to Rheonix leadership adds expertise in infectious diseases and global epidemic response ITHACA, N.Y. — Rheonix Inc., an innovative leader in highly multiplexed pathogen detection, announced the appointment of Stephen J. Thomas, M.D., as Chief Medical Officer and member of the Rheonix Board of Directors. "I am delighted to welcome Dr. Thomas to the Rheonix Board and as our Chief Medical Officer," said Greg Galvin, President, CEO and Chairman of… Read More »

Rheonix Receives FDA Clearance for Fully Automated Encompass MDx® Workstation and Molecular Test for Detection of Sexually Transmitted Infections

January 10, 2022 Press Release
Low-cost, scalable, sample-to-answer system provides flexibility and true walk-away testing ITHACA, N.Y. — Rheonix Inc., an innovative leader in highly multiplexed pathogen detection, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance of its automated Encompass MDx® Workstation, along with its STI TriPlex™ Assay and Male Urine Collection Kit for the detection of sexually transmitted infections (STI). “Rheonix is pleased to announce our FDA 510(k) approval for a… Read More »

The Rheonix COVID-19™ MDx Assay Reliably Detects Omicron (B.1.1.529) and other SARS-CoV-2 Variants of Concern

November 30, 2021 COVID-19, Press Release
Fully automated, scalable Rheonix method shows robust detection of variants ITHACA, N.Y. — Rheonix Inc. today announced that the Rheonix COVID-19™ MDx Assay will detect the newly emerging omicron variant of SARS-CoV-2, as well as other variants of public health concern. The company’s assessments indicate that its COVID-19 MDx Assay detects all SARS-CoV-2 variants of concern and variants being monitored by the World Health Organization (WHO) and U.S. Centers for Disease… Read More »

Roy Proujansky, M.D., and Irving Nachamkin, DrPH, Join Rheonix Board

January 29, 2021 COVID-19, Press Release
ITHACA, N.Y. — Rheonix Inc. today announced the appointment of Roy Proujansky, M.D., and Irving Nachamkin, DrPH, MPH, to its board of directors. "I'm honored to welcome Drs. Proujansky and Nachamkin to our board," said Greg Galvin, Ph.D., founder and CEO of Rheonix. "They join Rheonix at an exciting time as we provide critical testing solutions to address the pandemic and broaden our clinical diagnostic portfolio. The addition of these directors complements… Read More »

Archives